Daxdilimab
Daxdilimab is an anti-ILT7 monoclonal antibody, ILT7 is a cell surface molecule specific to the pDC type of dendritic cells. Daxdilimab can be used in acute lung injury (ALI) in patients with COVID-19 infection research[1][2].
Product Specifications
CAS Number
2245966-28-1
Product Name Alternative
MEDI7734; VIB7734
UNSPSC
12352203
Target
SARS-CoV
Type
Inhibitory Antibodies
Related Pathways
Anti-infection
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/daxdilimab.html
Purity
99.0
Solubility
10 mM in DMSO
Smiles
[Daxdilimab]
Molecular Weight
(144.38 kDa)
References & Citations
[1]Patel S, et al. Recent updates in the clinical trials of therapeutic monoclonal antibodies targeting cytokine storm for the management of COVID-19. Heliyon. 2021 Feb;7 (2) :e06158.|[2]Retamozo S, et al. An update of targeted therapeutic options for primary Sjögren syndrome: current status and future development. Expert Opin Pharmacother. 2021 Dec;22 (17) :2359-2371.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb1315501 100 µL
Prostate Specific Antigen (KLK3) Mouse Monoclonal Antibody
Sign In for Pricing
View Details ![Rabbit Polyclonal USP7 Antibody [DyLight 550]](https://cdn.genprice.uk/genprice/uk/genprice4.webp)